Adenovirus-mediated nitric oxide synthase gene transfer

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Nitric oxide (NO) has diverse biological effects, implicated in numerous physiological and pathophysiological processes.
• Understanding NO's roles is crucial for addressing diseases like atherosclerosis and vascular dysfunction.
• Gene transfer technologies offer novel ways to study NO and its associated enzymes, nitric oxide synthases (NOS).

Purpose of the Study:

• To investigate the therapeutic potential of nitric oxide synthase (NOS) gene transfer.
• To explore the localized delivery of NO using adenoviral vectors for therapeutic applications.
• To detail methods for creating and utilizing recombinant adenoviral vectors for NOS gene therapy.

Main Methods:

• Cloning of inducible nitric oxide synthase (iNOS) cDNA into a recombinant adenoviral vector.
• Large-scale production and preparation of the recombinant adenoviral vector (AdiNOS).
• Transduction of tissues in vitro and in vivo using the developed adenoviral vector.

Main Results:

• Adenoviral vectors enable efficient gene transfer for studying NO effects.
• Localized NO delivery via gene therapy can be achieved, potentially minimizing systemic side effects.
• The described methods facilitate the production and application of NOS gene therapy vectors.

Conclusions:

• NOS gene therapy, particularly using adenoviral vectors, shows promise for localized NO delivery.
• This approach can be instrumental in studying NO's role in vascular homeostasis and disease.
• The developed methodology provides a platform for further research into NO-based therapeutics.